Leuven (Belgium) – May 20, 2020. Materialise, a global leader in 3D printing, is launching Mindware as an advisory service to offer businesses strategic, tailored and technology-neutral insights on the use of 3D printing to address their business challenges. Mindware will be introduced by Bart Van Der Schueren, Chief Technology Officer at Materialise, via a live webinar on May 20 at 14:00 CEST.
Read more
LEUVEN, Belgium--(BUSINESS WIRE)—April 30, 2020 -- Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing and medical software and of sophisticated 3D printing services, today announced its financial results for the first quarter ended March 31, 2020.
Read more
In the fight against the coronavirus crisis, hospitals are in dire need of mechanical ventilators to treat COVID 19 patients. In response to this shortage, Materialise, a Belgium-based pioneer in 3D printing, has developed the Materialise NIP Connector, a device to convert standard equipment available in most hospitals, into a mask to facilitate breathing for patients by creating positive pressure in the lungs. These assembled masks allow clinicians to reduce the time patients need access to mechanical ventilators, which helps to reduce the strain on ventilator supplies. Materialise has decades of experience in certified medical 3D printing and is now fast-tracking the regulatory registrations that are crucial to ensure the safety of patients and caregivers. The company expects to have the device broadly available for hospitals by mid-April.
Read more
Door handles are among the most germ-infested objects in houses, hospitals, factories, and elderly homes. We stand behind our mission to build a better and healthier world, which is why we’re sharing a free design file for all worldwide for a hands-free 3D-printed door opener. By using your arm instead of your hands, we can work together to avoid further spreading COVID-19 and make a change!
Read more
Our Adjusted EBITDA rose by more than 13% to 26,7 million EUR. Materialise Software and Materialise Medical both achieved record quarterly revenues while Materialise Manufacturing experienced headwinds from a difficult macro-environment. We closed 2019 with cash and cash equivalents on our balance sheet totaling almost 129 million EUR, an increase of 13 million EUR compared to year-end 2018. We believe our continued solid and profitable growth and financial strength position us well to expand our existing business and capture new growth opportunities as our company enters its fourth decade and the additive manufacturing market continues to develop.”
Read more
